We Run Ultras

(14) The First Run After a Winter Illness Is a Check, Not a Catch-Up

By Francesco//8 min read/Training science & durability

Make the first session informative

After a winter respiratory illness, the first run should assess your response to exercise before you restore normal training. Feeling better at breakfast does not establish readiness for intervals that evening. A symptom-led return offers more useful information than catching up missed mileage, while allowing runners with genuinely mild illness to avoid an unnecessarily prolonged lay-off.

The familiar neck-check rule places symptoms above or below an anatomical boundary. The IOC consensus and Snyders' review describe its weak scientific foundation. It is not a validated clearance test. Illness severity, your usual health and the response when exercise resumes deserve more weight than whether discomfort sits above your collar. [1–2]

Severity matters more than a standard countdown

There is a credible argument against excessive caution. Snyders' review found that most recorded respiratory illnesses caused no training days to be lost, and Kaulback's performance review found relatively preserved endurance after some mild infections. Those observations describe what happened in studied athletes; they do not prove that continuing hard training is safe for everyone. [2–3]

Derman's risk-factor and incidence reviews show a heterogeneous problem across sports and populations, with winter among the associated risk factors. They do not provide a universal number of rest days. In the AWARE study, excessive fatigue was associated with longer return-to-play time. Jooste's later investigation of 116 confirmed infections found different severity patterns between viruses, including substantial variation within apparently familiar illnesses. [4–7]

Kaulback also found that a greater symptom burden during SARS-CoV-2 infection was associated with higher perceived exertion when athletes subsequently exercised. That makes unusually high effort relevant information, rather than evidence of weak motivation. These studies are largely observational and cannot turn an individual symptom into a precise recovery timetable. [8]

A winter cough is not a diagnosis

Repeated symptoms after cold-weather running deserve assessment if they persist or recur. The IOC's non-infective illness consensus, Spence's pathogen investigation and Gleeson's review distinguish infection from other causes of respiratory symptoms. Failure to identify a pathogen does not prove a non-infective cause, but assuming every cough is another virus can also mislead treatment. [9–11]

Bougault's environmental and air-quality reviews describe potential airway exposures while emphasising evidence gaps. Price's prevalence review identifies lower-airway dysfunction in athletic populations; Reier-Nilsen's diagnostic review shows why symptoms alone do not reliably settle the diagnosis. Clemm describes exercise-induced laryngeal obstruction, which can resemble asthma, while McIntosh examines nasal obstruction. These are reasons to investigate recurrent symptoms, not labels for runners to assign themselves. [12–17]

The distinction has a practical winter consequence. Repeatedly resting until a cough settles, then provoking it again with the same demanding outdoor session, may leave the underlying problem unresolved. A clinician can assess whether infection, airway dysfunction or another cause is driving that pattern.

Respect the symptoms that change the decision

Fever, marked exhaustion or feeling systemically unwell are reasons to defer running. Chest pain, unexplained breathlessness, palpitations or fainting warrant medical assessment before resuming exercise. Severe breathing difficulty or chest pain with tightness or heaviness requires emergency help: call 999. A short test run is not an appropriate way to investigate those symptoms. [1,18,26]

The ACC's COVID-19 pathway directs cardiac assessment towards relevant symptoms and clinical findings rather than routine scanning of every recovered athlete. Martinez's professional-athlete registry and Daniels' college-athlete registry used different screening approaches and found different frequencies of cardiac abnormalities. Their results should not be converted into a universal risk estimate for an ordinary winter cold. [18–20]

For a resolving mild illness without concerning symptoms, the IOC proposes a controlled exercise challenge, assessing the response after 10–20 minutes. Stop for abnormal symptoms or disproportionate effort, and review how you feel immediately afterwards and over the following 24 hours before increasing training. More substantial illness needs clinician-guided decisions. [1]

Rebuild from the response you observe

Neither a reassuring wearable score nor an isolated immune marker clears a runner. Neville found associations between changing salivary IgA and illness, whereas Vardiman did not find it a reliable indicator in female footballers. Even research biomarkers require context. Our HRV article makes the corresponding distinction for a familiar home measurement. [21–22]

Hausswirth linked overreaching with disturbed sleep and more illness in trained triathletes. Raysmith associated training availability with successful athletics seasons, but that finding does not justify training through infection. The coaching inference is to protect the weeks ahead instead of compressing missed work into this one. [23–24]

Choose a short, easily abandoned route for the first appropriate outing. Record symptoms and effort, then assess the following day before deciding what comes next. Persistent deterioration, including delayed worsening after activity, needs clinical review rather than a forced progression. Reduce exposure to training partners while infectious; NHS cold guidance supports rest and avoiding contact when feverish or too unwell for normal activities. [25]

Leave the missed intervals in the diary as missed. The next session should follow the recovery you observe.

Sources

Return to sport and illness severity

  1. Schwellnus M et al., "International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes part 1: acute respiratory infections" https://pubmed.ncbi.nlm.nih.gov/35863871/

  2. Snyders C et al., "Acute respiratory illness and return to sport: a systematic review and meta-analysis by a subgroup of the IOC consensus on 'acute respiratory illness in the athlete'" https://pubmed.ncbi.nlm.nih.gov/34789459/

  3. Kaulback K et al., "The effects of acute respiratory illness on exercise and sports performance outcomes in athletes - A systematic review by a subgroup of the IOC consensus group on "Acute respiratory illness in the athlete"" https://pubmed.ncbi.nlm.nih.gov/35695464/

  4. Derman W et al., "Risk factors associated with acute respiratory illnesses in athletes: a systematic review by a subgroup of the IOC consensus on 'acute respiratory illness in the athlete'" https://pubmed.ncbi.nlm.nih.gov/35277393/

  5. Derman W et al., "Incidence of acute respiratory illnesses in athletes: a systematic review and meta-analysis by a subgroup of the IOC consensus on 'acute respiratory illness in the athlete'" https://pubmed.ncbi.nlm.nih.gov/35260411/

  6. Schwellnus M et al., "Symptom cluster is associated with prolonged return-to-play in symptomatic athletes with acute respiratory illness (including COVID-19): a cross-sectional study-AWARE study I" https://pubmed.ncbi.nlm.nih.gov/33753345/

  7. Jooste M et al., "Clinical manifestations of different viral respiratory infections in athletes: implications for risk assessment and return-to-sport - AWARE VII study in 116 cases" https://pubmed.ncbi.nlm.nih.gov/40514645/

  8. Kaulback K et al., "Rating of Perceived Exertion Associated With Acute Symptoms in Athletes With Recent SARS-CoV-2 Infection: Athletes With Acute Respiratory InfEction (AWARE) VI Study" https://pubmed.ncbi.nlm.nih.gov/37347179/

Distinguishing infection from airway problems

  1. Schwellnus M et al., "International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes part 2: non-infective acute respiratory illness" https://pubmed.ncbi.nlm.nih.gov/35623888/

  2. Spence L et al., "Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes" https://pubmed.ncbi.nlm.nih.gov/17414793/

  3. Gleeson M et al., "Respiratory inflammation and infections in high-performance athletes" https://pubmed.ncbi.nlm.nih.gov/26568028/

  4. Bougault V et al., "Environmental factors associated with non-infective acute respiratory illness in athletes: A systematic review by a subgroup of the IOC consensus group on "acute respiratory illness in the athlete"" https://pubmed.ncbi.nlm.nih.gov/35365432/

  5. Bougault V et al., "Air quality, respiratory health and performance in athletes: a summary of the IOC consensus subgroup narrative review on 'Acute Respiratory Illness in Athletes'" https://pubmed.ncbi.nlm.nih.gov/39919804/

  6. Price OJ et al., "Prevalence of lower airway dysfunction in athletes: a systematic review and meta-analysis by a subgroup of the IOC consensus group on 'acute respiratory illness in the athlete'" https://pubmed.ncbi.nlm.nih.gov/34872908/

  7. Reier-Nilsen T et al., "Diagnostic approach to lower airway dysfunction in athletes: a systematic review and meta-analysis by a subgroup of the IOC consensus on 'acute respiratory illness in the athlete'" https://pubmed.ncbi.nlm.nih.gov/36717213/

  8. Clemm HH et al., "Exercise-induced laryngeal obstruction (EILO) in athletes: a narrative review by a subgroup of the IOC Consensus on 'acute respiratory illness in the athlete'" https://pubmed.ncbi.nlm.nih.gov/35193856/

  9. McIntosh C et al., "Diagnosis and management of nasal obstruction in the athlete. A narrative review by subgroup B of the IOC Consensus Group on "Acute Respiratory Illness in the Athlete"" https://pubmed.ncbi.nlm.nih.gov/34156184/

Cardiac assessment and its limits

  1. Gluckman TJ et al., "2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee" https://pubmed.ncbi.nlm.nih.gov/35307156/

  2. Martinez MW et al., "Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening" https://pubmed.ncbi.nlm.nih.gov/33662103/

  3. Daniels CJ et al., "Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry" https://pubmed.ncbi.nlm.nih.gov/34042947/

Monitoring, training continuity and public guidance

  1. Neville V et al., "Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes" https://pubmed.ncbi.nlm.nih.gov/18580401/

  2. Vardiman JP et al., "Salivary IgA is not a reliable indicator of upper respiratory infection in collegiate female soccer athletes" https://pubmed.ncbi.nlm.nih.gov/21519285/

  3. Hausswirth C et al., "Evidence of disturbed sleep and increased illness in overreached endurance athletes" https://pubmed.ncbi.nlm.nih.gov/24091995/

  4. Raysmith BP et al., "Performance success or failure is influenced by weeks lost to injury and illness in elite Australian track and field athletes: A 5-year prospective study" https://pubmed.ncbi.nlm.nih.gov/26839047/

  5. NHS, "Common cold" https://www.nhs.uk/conditions/common-cold/

  6. NHS, "Shortness of breath" https://www.nhs.uk/symptoms/shortness-of-breath/

Related work